Evidence map›Paper›PMID 30071181›Full record

ArticleRNA biology2018

RNA editing in bacteria: occurrence, regulation and significance.

Dan Bar-Yaacov, Yitzhak Pilpel, Orna Dahan

Open access · bronzeAbstract read
In one paragraph

Article in RNA biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Lactobacillus for ribosome peptide editing cancer.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2023
    Review
  13. Article
  14. Review
  15. Cas-Based Systems for RNA Editing in Gene Therapy of Monogenic Diseases:Frontiers in cell and developmental biology · 2022
    Review
  16. Review
  17. Article
  18. RNA Editing Detection in HPC Infrastructures.Methods in molecular biology (Clifton, N.J.) · 2021
    Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Dan Bar-Yaacova Morgridge Institute for Research , Madison , WI , USA.ORCID 0000-0002-0599-5153
Yitzhak Pilpelc Department of Molecular Genetics , Weizmann Institute of Science , Rehovot , Israel.
Orna Dahanc Department of Molecular Genetics , Weizmann Institute of Science , Rehovot , Israel.
Weizmann Institute of Science · ILUniversity of Wisconsin–Madison · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

DNA harbors the blueprint for life. However, the instructions stored in the DNA could be altered at the RNA level before they are executed. One of these processes is RNA editing, which was shown to modify RNA sequences in many organisms. The most abundant modification is the deamination of adenosine (A) into inosine (I). In turn, inosine can be identified as a guanosine (G) by the ribosome and other cellular machineries such as reverse transcriptase. In multicellular organisms, enzymes from the ADAR (adenosine deaminase acting on RNA) family mediate RNA editing in mRNA, whereas enzymes from the ADAT family mediate A-to-I editing on tRNAs. In bacteria however, until recently, only one editing site was described, in tRNA

Indexed as

AdenosineAdenosine DeaminaseBacterial ToxinsDeaminationDrug Resistance, BacterialInosineKlebsiella pneumoniaeRNA EditingRNA, MessengerRNA, TransferToxin-Antitoxin SystemsYersinia enterocoliticaAdenosineAdenosine DeaminaseBacterial ToxinsInosineRNA, MessengerRNA, TransferADARADATantibiotic tolerancebacteriahokBnon-genetic variationpersistenceRNA editingtadAtoxin-antitoxin

Identifiers

PMID30071181
PMCPMC6161690
OpenAlexW2886342695

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.